Adipocyte prolactin: Regulation of release and putative functions

Diabetes, Obesity and Metabolism

Volumn 9, Issue 4, 2007, Pages 464-476

  Brandebourg, T ^a   Hugo, E ^a   Ben Jonathan, Nira ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adipokines; Adipose tissue; Human adipocyte cell line; Obesity; Prolactin; Prolactin receptor

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROMOCRIPTINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE RECEPTOR BLOCKING AGENT; INSULIN; INTERLEUKIN 6; LEPTIN; PROLACTIN; PROLACTIN RECEPTOR;

ABDOMINAL FAT; ADIPOGENESIS; ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMOSOME 5; CHROMOSOME 6; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HORMONE INHIBITION; HORMONE SYNTHESIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; NONHUMAN; OBESITY; PROLACTIN RELEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; THERMOGENESIS; WHITE ADIPOSE TISSUE;

EID: 34347393307     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2006.00671.x     Document Type: Review

References (80)

1. Forsyth IA, Wallis M. Growth hormone and prolactin - molecular and functional evolution. J Mammary Gland Biol Neoplasia 2002; 7: 291-312.
2. Gourdji D, Laverriere JN. The rat prolactin gene: A target for tissue-specific and hormone-dependent transcription factors. Mol Cell Endocrinol 1994; 100: 133-142.
3. Goffin V, Shiverick KT, Kelly PA, Martial JA. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev 1996; 17: 385-410.
4. Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: Distribution, regulation, functions and clinical aspects. Endocr Rev 1996; 17: 639-669.
5. Keeler C, Dannies PS, Hodsdon ME. The tertiary structure and backbone dynamics of human prolactin. J Mol Biol 2003; 328: 1105-1121.
6. Sinha YN. Structural variants of prolactin: Occurrenceand physiological significance. Endocr Rev 1995; 16: 354-369.
7. Struman I, Bentzien F, Lee H et al. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci U S A 1999; 96: 1246-1251.
8. Walker AM. Unmodified and phosphorylated prolactin and gamma delta T cell development and function. Lupus 2001; 10: 735-741.
9. Ben-Jonathan N, Liu JW. Pituitary lactotrophs: Endocrine, paracrine, juxtacrine, and autocrine interactions. Trends Endocrinol Metab 1992; 3: 254-258.
10. Ben-Jonathan N, Hnasko RM. Dopamine as a prolactin inhibitor. Endocr Rev 2001; 22: 724-763.
11. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: Structure, function, and regulation of secretion. Physiol Rev 2000; 80: 1523-1631.
12. Pohnke Y, Kempf R, Gellersen B. CCAAT/enhancer-binding proteins are mediators in the protein kinase A-dependent activation of the decidual prolactin promoter. J Biol Chem 1999; 274: 24808-24818.
13. Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J Neuroimmunol 2005; 162: 190-193.
14. Gellersen B, Bonhoff A, Hunt N, Bohnet HG. Decidual-type prolactin expression by the human myometrium. Endocrinology 1991; 129: 158-168.
15. Shaw-Bruha CM, Pirrucello SJ, Shull JD. Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: Promoter usage and alternative mRNA splicing. Breast Cancer Res Treat 1997; 44: 243-253.
16. McFarland-Mancini M, Hugo E, Loftus J, Ben Jonathan N. Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands. Biochem Biophys Res Commun 2006; 344: 9-16.
17. Watanabe K, Kessler CA, Bachurski CJ et al. Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites. Mol Endocrinol 2001; 15: 638-653.
18. Gaasenbeek M, Gellersen B, di Mattia GE. DNase I hypersensitivity analysis of non-pituitary human prolactin gene expression. Mol Cell Endocrinol 1999; 152: 147-159.
19. Christian M, Pohnke Y, Kempf R, Gellersen B, Brosens JJ. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: Promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Mol Endocrinol 2002; 16: 141-154.
20. Handwerger S, Richards RG, Markoff E. The physiology of decidual prolactin and other decidual protein hormones. Trends Endocrinol Metab 1992; 3: 91-95.
21. Goffin V, Bernichtein S, Touraine P, Kelly PA. Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev 2005; 26: 400-422.
22. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003; 24: 1-27.
23. Horseman ND. Prolactin receptor diversity in humans: Novel isoforms suggest general principles. Trends Endocrinol Metab 2002; 13: 47-48.
24. Gutzman JH, Rugowski DE, Schroeder MD, Watters JJ, Schuler LA. Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells. Mol Endocrinol 2004; 18: 3064-3075.
25. Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A et al. Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Oncogene 2004; 23: 7378-7390.
26. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12: 207-233.
27. Rink JD, Simpson ER, Barnard JJ, Bulun SE. Cellular characterization of adipose tissue from various body sites of women. J Clin Endocrinol Metab 1996; 81: 2443-2447.
28. Ailhaud G. Molecular mechanisms of adipocyte differentiation. J Endocrinol 1997; 155: 201-202.
29. Gregoire FM. Adipocyte differentiation: From fibroblast to endocrine cell. Exp Biol Med (Maywood) 2001; 226: 997-1002.
30. Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 2000; 16: 145-171.
31. Sell H, Deshaies Y, Richard D. The brown adipocyte: Update on its metabolic role. Int J Biochem Cell Biol 2004; 36: 2098-2104.
32. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29: 72-75.
33. Trayhurn P, Beattie JH. Physiological role of adipose tissue: White adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 2001; 60: 329-339.
34. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 2002; 34: 616-621.
35. Lafontan M, Berlan M. Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol Sci 2003; 24: 276-283.
36. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-229.
37. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 2005; 8: 347-354.
38. Lawson DM, Sensui N, Haisenleder DH, Gala RR. Rat lymphoma cell bioassay for prolactin: Observations on its use and comparison with radioimmunoassay. Life Sci 1982; 31: 3063-3070.
39. Zinger M, McFarland M, Ben-Jonathan N. Prolactin expression and secretion by human breast glandular and adipose tissue. J Clin Endocrinol Metab 2003; 88: 689-696.
40. Kolset SO, Salmivirta M. Cell surface heparan sulfate proteoglycans and lipoprotein metabolism. Cell Mol Life Sci 1999; 56: 857-870.
41. Klagsbrun M. The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix. Endocrinology 1990; 2: 857-863.
42. Khurana S, Kuns R, Ben-Jonathan N. Heparin-binding property of human prolactin: A novel aspect of prolactin biology. Endocrinology 1999; 140: 1026-1029.
43. Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab 2004; 89: 4445-4449.
44. Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. Multiple, PKA-dependent and PKA-independent, signals are involved in cAMP-induced PRL expression in the eosinophilic cell line Eol-1. Cell Signal 2005; 17: 901-909.
45. Gellersen B, Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: A decidualizing affair. J Endocrinol 2003; 178: 357-372.
46. Telgmann R, Maronde E, Tasken K, Gellersen B. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells. Endocrinology 1997; 138: 929-937.
47. Pihoker C, Feeney RJ, Su JL, Handwerger S. Lipocortin-1 inhibits the synthesis and release of prolactin from human decidual cells: Evidence for autocrine/paracrine regulation by lipocortin 1. Endocrinology 1991; 128: 1123-1128.
48. Bonhoff A, Gellersen B. Modulation of prolactin secretion in human myometrium by cytokines. Eur J Obstet Gynecol Reprod Biol 1994; 54: 55-62.
49. Kanda Y, Jikihara H, Markoff E, Handwerger S. Interleukin-2 inhibits the synthesis and release of prolactin from human decidual cells. J Clin Endocrinol Metab 1999; 84: 677-681.
50. Hugo ER, Brandebourg TD, Comstock CE, Gersin KS, Sussman JJ, Ben-Jonathan N. LS14: A novel human adipocyte cell line that produces prolactin. Endocrinology 2006; 147: 306-313.
51. Collins S, Surwit RS. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog Horm Res 2001; 56: 309-328.
52. Vassiliou G, Benoist F, Lau P, Kavaslar GN, McPherson R. The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes. J Biol Chem 2001; 276: 48823-48830.
53. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev 1998; 78: 783-809.
54. Ginsburg E, Vonderhaar BK. Prolactin synthesis and secretion by human breast cancer cells. Cancer Res 1995; 55: 2591-2595.
55. Stewart WC, Baugh JE Jr, Floyd ZE, Stephens JM. STAT 5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem Biophys Res Commun 2004; 324: 355-359.
56. McAveney KM, Gimble JM, Yu-Lee LY. Prolactin receptor expression during adipocyte differentiation of bone marrow stroma. Endocrinology 1996; 137: 5723-5726.
57. Viengchareun S, Bouzinba-Segard H, Laigneau JP et al. Prolactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipocytes. J Mol Endocrinol 2004; 33: 679-691.
58. Fleenor D, Arumugam R, Freemark M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res 2006; 66: 101-110.
59. Nanbu-Wakao R, Fujitani Y, Masuho Y, Muramatu M, Wakao H. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol Endocrinol 2000; 14: 307-316.
60. Hauner H, Skurk T, Wabitsch M. In: Ailhaud G, ed. Adipose Tissue Protocols. Totowa, NJ: Humana Press, 2000; 239.
61. Ben Jonathan N, Hugo ER, Brandebourg TD, Lapensee CR. Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab 2006; 17: 110-116.
62. Lapensee CR, Horseman ND, Tso P, Brandebourg TD, Hugo ER, Ben-Jonathan N. The prolactin deficient mouse has an unaltered metabolic phenotype. Endocrinology 2006; 147: 4638-4645.
63. Baptista T, Lacruz A, Meza T et al. Antipsychotic drugs and obesity: Is prolactin involved? Can J Psychiatry 2001; 46: 829-834.
64. Doknic M, Pekic S, Zarkovic M et al. Dopaminergic tone and obesity: An insight from prolactinomas treated with bromocriptine. Eur J Endocrinol 2002; 147: 77-84.
65. Greenman Y, Tordjman K, Stern N. Increased body weight associated with prolactin secreting pituitary adenomas: Weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf) 1998; 48: 547-553.
66. Ling C, Svensson L, Oden B et al. Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J Clin Endocrinol Metab 2003; 88: 1804-1808.
67. Barber MC, Clegg RA, Finley E, Vernon RG, Flint DJ. The role of growth hormone, prolactin and insulin-like growth factors in the regulation of rat mammary gland and adipose tissue metabolism during lactation. J Endocrinol 1992; 135: 195-202.
68. Spooner PM, Chernick SS, Garrison MM, Scow RO. Development of lipoprotein lipase activity and accumulation of triacylglycerol in differentiating 3T3-L1 adipocytes. Effects of prostaglandin F2alpha, 1-methyl-3-isobutylxanthine, prolactin, and insulin. J Biol Chem 1979; 254: 1305-1311.
69. Hogan JC, Stephens JM. The regulation of fatty acid synthase by STAT5A. Diabetes 2005; 54: 1968-1975.
70. Kobayashi K Adipokines: Therapeutic targets for metabolic syndrome. Curr Drug Targets 2005; 6: 525-529.
71. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
72. Guerre-Millo M. Adipose tissue and adipokines: For better or worse. Diabetes Metab 2004; 30: 13-19.
73. Ling C, Billig H. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro. Endocrinology 2001; 142: 4880-4890.
74. Freemark M, Fleenor D, Driscoll P, Binart N, Kelly P. Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 2001; 142: 532-537.
75. Fleenor D, Oden J, Kelly PA et al. Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: Studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology 2005; 146: 103-112.
76. Combs TP, Berg AH, Rajala MW et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003; 52: 268-276.
77. Nilsson L, Binart N, Bohlooly Y et al. Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 2005; 331: 1120-1126.
78. Ling C, Kindblom J, Wennbo H, Billig H. Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Lett 2001; 507: 147-150.
79. Brelje TC, Stout LE, Bhagroo NV, Sorenson RL. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans. Endocrinology 2004; 145: 4162-4175.
80. Nielsen JH, Galsgaard ED, Moldrup A et al. Regulation of beta-cell mass by hormones and growth factors. Diabetes 2001; 50 (Suppl. 1): S25-S29.